News

Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript

Claritev Corporation (NYSE:MPLN) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Shawna Gasik - Assistant

News

Editor's Top Picks

White House official pushes to axe Canada from Five Eyes intelligence group

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election means for Washington and the

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Europe’s real tourist trap

Stay informed with free updatesSimply sign up to the Life & Arts myFT Digest --

Could AI make you a better investor?

“Isn’t that cheating?” asked Uncle Trevor as I triumphantly identified a willow warbler using an

Yoox Net-a-Porter exits China to focus on more profitable markets

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories

A day in the life of the US ambassador to China

It is strangely fitting that Nicholas Burns, America’s ambassador in Beijing, began his job at

Even Apple cannot explain why we need AI in our lives

Stay informed with free updatesSimply sign up to the Technology sector myFT Digest -- delivered

How the fairies shrunk the wild flowers in the Burren

As summer gloomily succeeded Britain’s spring, my garden was overrun with weeds. They are not

Elon Musk takes victory lap after 77% of Tesla shareholder votes back his $56bn pay

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories

Tesla shareholders will have no one to blame if things go south

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories

Italian football prosecutor dismisses case over Elliott’s AC Milan sale

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories

Carlyle explores sale of electric power producer Cogentrix Energy

Stay informed with free updatesSimply sign up to the Utilities myFT Digest -- delivered directly

Boeing and Airbus bought metal for planes that was falsely certified

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories

The relentless rise of France’s far right

Sitting on the terrace of a café, Daniel, a 60-year-old retired building contractor, is reluctant

The Barclay heir battling bankruptcy, the Seigneur, and the Sark IPO

The last known feudal lord in the world is leaning back against a disused door,

US Supreme Court overturns ‘bump stock’ ban in blow for firearm restrictions

Unlock the US Election Countdown newsletter for freeThe stories that matter on money and politics

Stoke Therapeutics’ STK-001: A Potential Game-Changer For Dravet Syndrome (NASDAQ:STOK)

Stoke Therapeutics (NASDAQ:STOK) is a biotechnology company developing RNA-based therapies for severe genetic diseases caused